{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T18:58:55Z","timestamp":1793905135417,"version":"4.8.0"},"reference-count":73,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>COVID-19 might affect the incidence of specific neurological diseases, but it is unknown if this differs from the risk following other infections. Here, we characterized the frequency of neurodegenerative, cerebrovascular, and immune-mediated neurological diseases after COVID-19 compared to individuals without COVID-19 and those with other respiratory tract infections.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This population-based cohort study utilized electronic health records covering ~50% of Denmark's population (<jats:italic>n<\/jats:italic> = 2,972,192). Between 02\/2020 and 11\/2021, we included individuals tested for COVID-19 or diagnosed with community-acquired bacterial pneumonia in hospital-based facilities. Additionally, we included individuals tested for influenza in the corresponding pre-pandemic period between 02\/ 2018 and 11\/2019. We stratified cohorts for in- and outpatient status, age, sex, and comorbidities.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In total, 919,731 individuals were tested for COVID-19, of whom 43,375 tested positive (35,362 outpatients, 8,013 inpatients). Compared to COVID-negative outpatients, COVID-19 positive outpatients had an increased RR of Alzheimer's disease (RR = 3.5; 95%CI: 2.2\u20135.5) and Parkinson's disease (RR = 2.6; 95%CI: 1.7\u20134.0), ischemic stroke (RR = 2.7; 95%CI: 2.3\u20133.2) and intracerebral hemorrhage (RR = 4.8; 95%CI: 1.8\u201312.9). However, when comparing to other respiratory tract infections, only the RR for ischemic stroke was increased among inpatients with COVID-19 when comparing to inpatients with influenza (RR = 1.7; 95%CI: 1.2\u20132.4) and only for those &amp;gt;80 years of age when comparing to inpatients with bacterial pneumonia (RR = 2.7; 95%CI: 1.2\u20136.2). Frequencies of multiple sclerosis, myasthenia gravis, Guillain-Barr\u00e9 syndrome and narcolepsy did not differ after COVID-19, influenza and bacterial pneumonia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The risk of neurodegenerative and cerebrovascular, but not neuroimmune, disorders was increased among COVID-19 positive outpatients compared to COVID-negative outpatients. However, except for ischemic stroke, most neurological disorders were not more frequent after COVID-19 than after other respiratory infections.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2022.904796","type":"journal-article","created":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T06:06:51Z","timestamp":1655964411000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":60,"title":["Frequency of Neurological Diseases After COVID-19, Influenza A\/B and Bacterial Pneumonia"],"prefix":"10.3389","volume":"13","author":[{"given":"Pardis","family":"Zarifkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costanza","family":"Peinkhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Benros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Kondziella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1002\/acn3.51210","article-title":"Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients","volume":"7","author":"Liotta","year":"2020","journal-title":"Ann Clin Transl Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e2112131","DOI":"10.1001\/jamanetworkopen.2021.12131","article-title":"Global incidence of neurological manifestations among patients hospitalized with COVID-19-a report for the GCS-NeuroCOVID consortium and the ENERGY consortium","volume":"4","author":"Chou","year":"2021","journal-title":"JAMA Netw Open."},{"key":"B3","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1161\/STROKEAHA.120.031786","article-title":"Acute ischemic stroke and COVID-19: an analysis of 27 676 patients","volume":"52","author":"Qureshi","year":"2021","journal-title":"Stroke."},{"key":"B4","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1136\/jnnp-2020-324927","article-title":"Characteristics and outcomes of COVID-19 associated stroke: a UK multicentre case-control study","volume":"92","author":"Perry","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B5","doi-asserted-by":"publisher","first-page":"598272","DOI":"10.3389\/fmed.2020.598272","article-title":"Thirty-day mortality and morbidity in COVID-19 positive vs. COVID-19 negative individuals and vs individuals tested for influenza A\/B: a population-based study","volume":"7","author":"Nersesjan","year":"2020","journal-title":"Front Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.brainresbull.2021.12.011","article-title":"Risk of ischemic stroke in patients with COVID-19 infection: a systematic review and meta-analysis","volume":"180","author":"Cui","year":"2022","journal-title":"Brain Res Bull."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1111\/jth.14849","article-title":"Thromboinflammation and the hypercoagulability of COVID-19","volume":"18","author":"Connors","year":"2020","journal-title":"J Thromb Haemost."},{"key":"B8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s41030-020-00126-5","article-title":"The interplay between coagulation and inflammation pathways in COVID-19-associated respiratory failure: a narrative review","volume":"6","author":"Bhattacharyya","year":"2020","journal-title":"Pulm Ther."},{"key":"B9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.33588\/rn.7206.2020487","article-title":"Guillain-barre syndrome associated to COVID-19 infection: a review of published case reports","volume":"72","author":"Zuberbuhler","year":"2021","journal-title":"Rev Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1186\/s12967-020-02670-9","article-title":"Parkinson's disease following COVID-19: causal link or chance occurrence?","volume":"18","author":"Li","year":"2020","journal-title":"J Transl Med."},{"key":"B11","unstructured":""},{"key":"B12","unstructured":""},{"key":"B13","doi-asserted-by":"publisher","first-page":"e2029540","DOI":"10.1001\/jamanetworkopen.2020.29540","article-title":"Delirium in older patients with COVID-19 presenting to the emergency department","volume":"3","author":"Kennedy","year":"2020","journal-title":"JAMA Netw Open."},{"key":"B14","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1001\/jama.2010.167","article-title":"Association between acute care and critical illness hospitalization and cognitive function in older adults","volume":"303","author":"Ehlenbach","year":"2010","journal-title":"JAMA."},{"key":"B15","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/jama.2011.1964","article-title":"Association of incident dementia with hospitalizations","volume":"307","author":"Phelan","year":"2012","journal-title":"JAMA."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1093\/brain\/aws190","article-title":"Delirium is a strong risk factor for dementia in the oldest-old: a population-based cohort study","volume":"135","author":"Davis","year":"2012","journal-title":"Brain."},{"key":"B17","unstructured":""},{"key":"B18","unstructured":""},{"key":"B19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.amsu.2020.09.016","article-title":"A snapshot of ischemic stroke risk factors, sub-types, and its epidemiology: cohort study","volume":"59","author":"Alawneh","year":"2020","journal-title":"Ann Med Surg."},{"key":"B20","doi-asserted-by":"publisher","first-page":"691136","DOI":"10.3389\/fncel.2021.691136","article-title":"Microbial infections are a risk factor for neurodegenerative diseases","volume":"15","author":"Lotz","year":"2021","journal-title":"Front Cell Neurosci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S1474-4422(16)30076-X","article-title":"Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis","volume":"15","author":"Whiteley","year":"2016","journal-title":"Lancet Neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.neuron.2018.11.043","article-title":"Alzheimer's disease-associated beta-amyloid is rapidly seeded by herpesviridae to protect against brain infection","volume":"100","author":"Eimer","year":"2018","journal-title":"Neuron."},{"key":"B23","doi-asserted-by":"publisher","first-page":"340ra372","DOI":"10.1126\/scitranslmed.aaf1059","article-title":"Amyloid-beta peptide protects against microbial infection in mouse and worm models of Alzheimer's disease","volume":"8","author":"Kumar","year":"2016","journal-title":"Sci Transl Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3389\/fnagi.2018.00048","article-title":"Molecular mechanisms for herpes simplex virus type 1 pathogenesis in Alzheimer's disease","volume":"10","author":"Harris","year":"2018","journal-title":"Front Aging Neurosci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3389\/fneur.2019.00122","article-title":"Inflammation, infectious triggers, and Parkinson's disease","volume":"10","author":"Caggiu","year":"2019","journal-title":"Front Neurol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1523\/JNEUROSCI.5123-11.2012","article-title":"Inflammatory effects of highly pathogenic H5N1 influenza virus infection in the CNS of mice","volume":"32","author":"Jang","year":"2012","journal-title":"J Neurosci."},{"key":"B27","unstructured":"?-Amyloid Deposits in Young COVID Patients\n            HarkerRC\n            PriemerDS"},{"key":"B28","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.parkreldis.2010.06.012","article-title":"Parkinsonism and neurological manifestations of influenza throughout the 20th and 21st centuries","volume":"16","author":"Henry","year":"2010","journal-title":"Parkinsonism Relat Disord."},{"key":"B30","doi-asserted-by":"publisher","first-page":"6741","DOI":"10.1073\/pnas.1906466117","article-title":"Disruption of cellular proteostasis by H1N1 influenza A virus causes alpha-synuclein aggregation","volume":"117","author":"Marreiros","year":"2020","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B31","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1093\/infdis\/jiu437","article-title":"Cytomegalovirus infection and risk of Alzheimer disease in older black and white individuals","volume":"211","author":"Barnes","year":"2015","journal-title":"J Infect Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e2130645","DOI":"10.1001\/jamanetworkopen.2021.30645","article-title":"Assessment of cognitive function in patients after COVID-19 infection","volume":"4","author":"Becker","year":"2021","journal-title":"JAMA Netw Open."},{"key":"B33","doi-asserted-by":"publisher","first-page":"101044","DOI":"10.1016\/j.eclinm.2021.101044","article-title":"Cognitive deficits in people who have recovered from COVID-19","volume":"39","author":"Hampshire","year":"2021","journal-title":"EClinicalMedicine."},{"key":"B34","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s12640-012-9348-1","article-title":"Neuroinflammation, neurodegeneration, and depression","volume":"23","author":"Hurley","year":"2013","journal-title":"Neurotox Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1161\/STROKEAHA.120.030335","article-title":"SARS-CoV-2 and stroke in a new york healthcare system","volume":"51","author":"Yaghi","year":"2020","journal-title":"Stroke."},{"key":"B36","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.1161\/STROKEAHA.121.034787","article-title":"Risk, clinical course, and outcome of ischemic stroke in patients hospitalized with COVID-19: a multicenter cohort study","volume":"52","author":"Sluis","year":"2021","journal-title":"Stroke."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1007\/s00415-021-10837-7","article-title":"Ischemic stroke associated with COVID-19: a systematic review and meta-analysis","volume":"269","author":"Luo","year":"2022","journal-title":"J Neurol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e2269","DOI":"10.1212\/WNL.0000000000012930","article-title":"Frequency of neurologic manifestations in COVID-19: a systematic review and meta-analysis","volume":"97","author":"Misra","year":"2021","journal-title":"Neurology."},{"key":"B39","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12883-021-02075-1","article-title":"Stroke etiologies in patients with COVID-19: the SVIN COVID-19 multinational registry","volume":"21","author":"Ramos-Araque","year":"2021","journal-title":"BMC Neurol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1161\/str.52.suppl_1.P81","article-title":"SARS-CoV-2 and stroke characteristics: a report from the multinational COVID-19 stroke study group","volume":"52","author":"Shahjouei","year":"2021","journal-title":"Stroke."},{"key":"B41","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s10072-021-05679-0","article-title":"A review of ischemic stroke in COVID-19: currently known pathophysiological mechanisms","volume":"43","author":"Tang","year":"2022","journal-title":"Neurol Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1056\/NEJMoa041747","article-title":"Risk of myocardial infarction and stroke after acute infection or vaccination","volume":"351","author":"Smeeth","year":"2004","journal-title":"N Engl J Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41591-021-01630-0","article-title":"Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection","volume":"28","author":"Patone","year":"2022","journal-title":"Nat Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"649922","DOI":"10.3389\/fcvm.2021.649922","article-title":"Stroke in SARS-CoV-2 infection: a pictorial overview of the pathoetiology","volume":"8","author":"Aghayari Sheikh Neshin","year":"2021","journal-title":"Front Cardiovasc Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"100012","DOI":"10.1016\/j.clinsp.2022.100012","article-title":"Ischemic stroke in 455 COVID-19 patients","volume":"77","author":"Finsterer","year":"2022","journal-title":"Clinics."},{"key":"B46","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.hest.2021.11.003","article-title":"The relationship between COVID-19 infection and intracranial hemorrhage: a systematic review","volume":"2","author":"Daly","year":"2021","journal-title":"Brain Hemorrhages."},{"key":"B47","doi-asserted-by":"publisher","first-page":"104984","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104984","article-title":"Hemorrhagic stroke and anticoagulation in COVID-19","volume":"29","author":"Dogra","year":"2020","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.3174\/ajnr.A6793","article-title":"Brain Imaging of patients with COVID-19: findings at an academic institution during the height of the outbreak in New York City","volume":"41","author":"Lin","year":"2020","journal-title":"AJNR Am J Neuroradiol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"e0248728","DOI":"10.1371\/journal.pone.0248728","article-title":"Impact of COVID-19 on the hospitalization, treatment, and outcomes of intracerebral and subarachnoid hemorrhage in the United States","volume":"16","author":"Ravindra","year":"2021","journal-title":"PLoS ONE."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e615","DOI":"10.1016\/j.wneu.2021.04.089","article-title":"Subarachnoid hemorrhage and COVID-19: an analysis of 282,718 patients","volume":"151","author":"Qureshi","year":"2021","journal-title":"World Neurosurg."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1056\/NEJMc2009191","article-title":"Guillain-barre syndrome associated with SARS-CoV-2","volume":"382","author":"Toscano","year":"2020","journal-title":"N Engl J Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"6045","DOI":"10.1002\/jmv.27159","article-title":"COVID-19-associated guillain-barre syndrome: postinfectious alone or neuroinvasive too?","volume":"93","author":"Khan","year":"2021","journal-title":"J Med Virol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1093\/brain\/awaa433","article-title":"Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barre syndrome","volume":"144","author":"Keddie","year":"2021","journal-title":"Brain."},{"key":"B54","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ncl.2013.01.005","article-title":"Guillain-barre syndrome and variants","volume":"31","author":"Dimachkie","year":"2013","journal-title":"Neurol Clin."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s00415-020-10131-y","article-title":"COVID-19: dealing with a potential risk factor for chronic neurological disorders","volume":"268","author":"Schirinzi","year":"2021","journal-title":"J Neurol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"102377","DOI":"10.1016\/j.msard.2020.102377","article-title":"Multiple sclerosis following SARS-CoV-2 infection","volume":"45","author":"Palao","year":"2020","journal-title":"Mult Scler Relat Disord."},{"key":"B57","doi-asserted-by":"publisher","first-page":"695","DOI":"10.3390\/neurolint13040066","article-title":"Clinical onset and multiple sclerosis relapse after SARS-CoV-2 infection","volume":"13","author":"Pignolo","year":"2021","journal-title":"Neurol Int."},{"key":"B58","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00415-021-10648-w","article-title":"First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine","volume":"269","author":"Havla","year":"2022","journal-title":"J Neurol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.3390\/v13102091","article-title":"The potential role of COVID-19 in the pathogenesis of multiple sclerosis-a preliminary report","volume":"13","author":"Satheesh","year":"2021","journal-title":"Viruses"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.7326\/L20-0845","article-title":"Myasthenia gravis associated with SARS-CoV-2 infection","volume":"173","author":"Restivo","year":"2020","journal-title":"Ann Intern Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.21203\/rs.3.rs-790941\/v1","article-title":"Myasthenia gravis exacerbation and myasthenic crisis associated with COVID-19: case series and literature review","volume":"43","author":"Rodrigues","year":"2022","journal-title":"Neurol Sci."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1111\/cns.13438","article-title":"Narcolepsy with cataplexy: does age at diagnosis change the clinical picture?","volume":"26","author":"Zhang","year":"2020","journal-title":"CNS Neurosci Ther."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1001\/jamaneurol.2020.1512","article-title":"Assessment of incidence and risk factors of intracerebral hemorrhage among participants in the framingham heart study between 1948 and 2016","volume":"77","author":"Lioutas","year":"2020","journal-title":"JAMA Neurol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2147\/CLEP.S197251","article-title":"The positive predictive value of spontaneous subarachnoid hemorrhage diagnoses in the Danish national patient register","volume":"11","author":"Sonne","year":"2019","journal-title":"Clin Epidemiol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/1471-2377-13-156","article-title":"Temporal trends in stroke admissions in Denmark 1997-2009","volume":"13","author":"Demant","year":"2013","journal-title":"BMC Neurol."},{"key":"B66","unstructured":""},{"key":"B67","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/ane.13535","article-title":"Stroke admissions and revascularization treatments in Denmark during COVID-19","volume":"145","author":"Drenck","year":"2022","journal-title":"Acta Neurol Scand."},{"key":"B68","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1136\/jnnp-2020-324837","article-title":"Guillain-Barre syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions","volume":"92","author":"Filosto","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B69","unstructured":""},{"key":"B70","doi-asserted-by":"publisher","first-page":"102677","DOI":"10.1016\/j.msard.2020.102677","article-title":"Association of multiple sclerosis with PM 2. 5 levels further evidence from the highly polluted area of Padua Province, Italy","volume":"48","author":"Scartezzini","year":"2021","journal-title":"Mult Scler Relat Disord."},{"key":"B71","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/ane.13223","article-title":"Air pollution, a possible risk factor for multiple sclerosis","volume":"141","author":"Turk Boru","year":"2020","journal-title":"Acta Neurol Scand."},{"key":"B72","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1007\/s11356-020-10595-5","article-title":"PM2. 5 exposure as a risk factor for multiple sclerosis an ecological study with a bayesian mapping approach","volume":"28","author":"Bergamaschi","year":"2021","journal-title":"Environ Sci Pollut Res Int"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1177\/1352458513513968","article-title":"Sun exposure and multiple sclerosis risk in Norway and Italy: the EnvIMS study","volume":"20","author":"Bjornevik","year":"2014","journal-title":"Mult Scler."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.904796\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T06:06:55Z","timestamp":1655964415000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.904796\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,23]]},"references-count":73,"alternative-id":["10.3389\/fneur.2022.904796"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.904796","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,23]]},"article-number":"904796"}}